| Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018 | 3917 | 2018 |
| Tumor microbiome diversity and composition influence pancreatic cancer outcomes E Riquelme, Y Zhang, L Zhang, M Montiel, M Zoltan, W Dong, P Quesada, ... Cell 178 (4), 795-806. e12, 2019 | 1031 | 2019 |
| Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer Y Zhang, V Chandra, E Riquelme Sanchez, P Dutta, PR Quesada, ... Journal of experimental medicine 217 (12), 2020 | 267 | 2020 |
| Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis T Takahashi, N Shivapurkar, E Riquelme, H Shigematsu, J Reddy, ... Clinical Cancer Research 10 (18), 6126-6133, 2004 | 160 | 2004 |
| EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non–small cell lung carcinoma C Behrens, LM Solis, H Lin, P Yuan, X Tang, H Kadara, E Riquelme, ... Clinical cancer research 19 (23), 6556-6565, 2013 | 156 | 2013 |
| Immune cell production of interleukin 17 induces stem cell features of pancreatic intraepithelial neoplasia cells Y Zhang, M Zoltan, E Riquelme, H Xu, I Sahin, S Castro-Pando, ... Gastroenterology 155 (1), 210-223. e3, 2018 | 127 | 2018 |
| Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations E Riquelme, C Behrens, HY Lin, G Simon, V Papadimitrakopoulou, J Izzo, ... Cancer research 76 (3), 675-685, 2016 | 117 | 2016 |
| Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma E Riquelme, MB Suraokar, J Rodriguez, B Mino, HY Lin, DC Rice, A Tsao, ... Journal of Thoracic Oncology 9 (7), 998-1007, 2014 | 101 | 2014 |
| Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma II Wistuba, R Ashfaq, A Maitra, H Alvarez, E Riquelme, AF Gazdar The American journal of pathology 160 (6), 2073-2079, 2002 | 88 | 2002 |
| Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma E Riquelme, M Tang, S Baez, A Diaz, M Pruyas, II Wistuba, A Corvalan Cancer letters 250 (1), 100-106, 2007 | 81 | 2007 |
| Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands R Pacheco, E Riquelme, AM Kalergis Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2010 | 76 | 2010 |
| Mitochondrial DNA mutation at the D310 (displacement loop) mononucleotide sequence in the pathogenesis of gallbladder carcinoma M Tang, S Baez, M Pruyas, A Diaz, A Calvo, E Riquelme, II Wistuba Clinical cancer research 10 (3), 1041-1046, 2004 | 76 | 2004 |
| Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non–small-cell lung carcinoma who receive adjuvant chemotherapy F Yang, X Tang, E Riquelme, C Behrens, MB Nilsson, U Giri, ... Cancer research 71 (16), 5512-5521, 2011 | 75 | 2011 |
| Immune profiling of premalignant lesions in patients with lynch syndrome K Chang, MW Taggart, L Reyes-Uribe, E Borras, E Riquelme, RM Barnett, ... JAMA oncology 4 (8), 1085-1092, 2018 | 72 | 2018 |
| VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2–targeted therapy E Riquelme, M Suraokar, C Behrens, HY Lin, L Girard, MB Nilsson, ... Clinical Cancer Research 20 (14), 3849-3861, 2014 | 69 | 2014 |
| Immunotherapy for pancreatic cancer: more than just a gut feeling E Riquelme, A Maitra, F McAllister Cancer discovery 8 (4), 386-388, 2018 | 61 | 2018 |
| Mismatch repair expression in testicular cancer predicts recurrence and survival A Velasco, A Corvalan, II Wistuba, E Riquelme, R Chuaqui, A Majerson, ... International journal of cancer 122 (8), 1774-1777, 2008 | 56 | 2008 |
| Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis P Macanas-Pirard, A Leisewitz, R Broekhuizen, K Cautivo, FM Barriga, ... PLoS One 7 (5), e37203, 2012 | 42 | 2012 |
| The duration of TCR/pMHC interactions regulates CTL effector function and tumor‐killing capacity E Riquelme, LJ Carreño, PA González, AM Kalergis European journal of immunology 39 (8), 2259-2269, 2009 | 42 | 2009 |
| Microsatellite instability and loss of heterozygosity have distinct prognostic value for testicular germ cell tumor recurrence A Velasco, E Riquelme, M Schultz, II Wistuba, L Villarroel, MS Koh, ... Cancer Biology & Therapy 3 (11), 1152-1158, 2004 | 42 | 2004 |
